## **Core Concept**
The question targets the prevention of mother-to-child transmission (PMTCT) of a specific infection during childbirth, focusing on the role of antiretroviral therapy. The key concept here involves understanding the drugs used to prevent the vertical transmission of HIV.

## **Why the Correct Answer is Right**
The correct answer, Nevirapine, is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used in the prevention of mother-to-child transmission of HIV. A single dose of Nevirapine given to the mother at the onset of labor, followed by a single dose given to the newborn within 72 hours of birth, has been shown to significantly reduce the risk of HIV transmission from mother to child. This regimen is effective, easy to administer, and has been widely used in resource-limited settings.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is blank and does not provide a drug name for evaluation.
- **Option B:** This option is also blank and cannot be assessed.
- **Option D:** Similarly, this option does not provide a drug name and thus cannot be evaluated.

## **Clinical Pearl / High-Yield Fact**
A critical point to remember is that Nevirapine is specifically used for the prevention of mother-to-child transmission of HIV, especially in settings where more complex interventions might not be feasible. This regimen has been a game-changer in reducing the rate of HIV transmission from mothers to their children during birth.

## **Correct Answer:** . Nevirapine